Clearwater International advises on sale of pharma equipment manufacturer to US PE firm

Birmingham’s Clearwater International has advised private equity firm LDC on the sale of a pharmaceutical equipment manufacturer to San Francisco-based Arcline Investment Management.

The deal will see Liverpool-based ChargePoint Technology become part of Arcline’s broader speciality process technologies platform offering and enable it to strengthen its global presence.

The transaction marks an exit for LDC following a four-year partnership.

ChargePoint manufactures and delivers enhanced sterile and containment process solutions to companies across Europe, Asia and North America.

Its and helps transfer highly potent and sterile powders safely within advanced manufacturing facilities.

The Clearwater International team comprised partner Paul Jones, director Mark Gillingham, associate director Zack Goddard and senior associate Dom Moir.

Debt advisory support was provided by managing partner Mark Taylor, director Tom Barnwell and senior associate Ryan Howarth.

Paul Jones, partner, Clearwater International, said: “Since LDC’s investment in 2017, the business has grown exceptionally well, adding a range of single use technologies to its leading multi-use containment system.

“ChargePoint is now uniquely positioned as a scalable platform with investment opportunities through both new product development and strategic bolt on acquisitions.”